http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007135470-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac3e787a6871df4284213bb52de1883d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
filingDate 2003-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa8aea75aabe1a196105e8e6c61bd9d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cb19c93b6918532acc87bf0ad8944a9
publicationDate 2007-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2007135470-A1
titleOfInvention Utilization of vinpocetine to avoid complications in particular those associated to hearing which occur with epilepsy, and treatment thereof
abstract The present invention is related with the use of vinpocetine and the derivates developed from its formula that maintains the same effects for the treatment of epilepsy and its complications. Our results show that vinpocetine prevents all the abnormalities of the ABR waves that accompany the epileptic cortical activity observed for the ictal and post-ictal periods in two experimental models of epilepsy in vivo, that vinpocetine also inhibits the marked hearing loss and the characteristic EEG changes induced by two convulsing agents that differ in their mechanisms of action. These findings also indicate that the capacity of vinpocetine as an antiepileptic drug is not accompanied by adverse secondary effects.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3255044-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017039670-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014100475-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107614498-A
priorityDate 2003-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4882336-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128923565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57112289
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554878
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135735641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135988791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395615
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504036
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135960706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2802
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128756319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127838758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408128213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127729747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3549980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127692443
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226542081
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411653
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443955
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5665
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128706830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493326
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433619
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5917

Total number of triples: 69.